Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051980
Filing Date
2020-11-06
Accepted
2020-11-06 16:16:57
Documents
87
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qtnt-10q_20200930.htm   iXBRL 10-Q 3478517
2 EX-10.1 qtnt-ex101_363.htm EX-10.1 13573
3 EX-10.2 qtnt-ex102_267.htm EX-10.2 14019
4 EX-31.1 qtnt-ex311_8.htm EX-31.1 16380
5 EX-31.2 qtnt-ex312_6.htm EX-31.2 16440
6 EX-32.1 qtnt-ex321_9.htm EX-32.1 5134
7 EX-32.2 qtnt-ex322_7.htm EX-32.2 5136
8 GRAPHIC gpoe5qehrsjn000001.jpg GRAPHIC 3060
  Complete submission text file 0001564590-20-051980.txt   12100660

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20200930.xsd EX-101.SCH 65758
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20200930_cal.xml EX-101.CAL 88080
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20200930_def.xml EX-101.DEF 199067
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20200930_lab.xml EX-101.LAB 523935
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20200930_pre.xml EX-101.PRE 408756
14 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-10q_20200930_htm.xml XML 2506755
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-36415 | Film No.: 201294619
SIC: 2835 In Vitro & In Vivo Diagnostic Substances